UK-based patient recruitment and trial management business Synexus is expanding its operations in Gydnia, where it acquired a clinical trial centre along with two others in Poland last August.
The new dedicated research centre in Gydnia will have capacity for four full-time investigators, with the available space increasing from 100sq m to 300sq m.
The centre will include a wide range of diagnostic instruments in line with Synexus’s widening therapy area coverage, noted the company, which also recently added several hundred square metres of space to its original Polish centre in Wroclaw.
Last August Synexus completed the acquisition of CLCC, which operated three clinical trial centres in the major Polish conurbations of Warsaw, Gdynia and Katowice. The company has been active in Poland since 2006.
According to Dr Radoslaw Janiak, Synexus’ country manager for Poland, the local centres are increasingly involved in large global clinical trials, capitalising on their ability to “recruit the right number of patients within the right time frame”.
